Keywords: Deuterium Metabolic Imaging (DMI); GBM; Magnetic Resonance Spectroscopy (MRS); cancer metabolism; central nervous system (CNS); epilepsy; lower-grade glioma (LGG); subarachnoid hemorrhage.